EyeCare Partners Acquires Kentucky/Indiana’s 20/20 EyeCare’s Seven Offices

By Staff
Monday, December 10, 2018 12:27 AM ST. LOUIS—EyeCare Partners, LLC (ECP) has announced its acquisition of 20/20 EyeCare, the Louisville, Kentucky, and Southern Indiana optometry practice of Kevin Crawford, OD. Dr. Crawford opened the first 20/20 practice in Elizabethtown, Kentucky, in 1988. Over the last 30 years, 20/20 has expanded to seven locations in Greater Louisville and Southern Indiana. The practice’s 12 doctors offer comprehensive eye exams and a range of advanced treatments for ocular disease, specializing in dry eye, glaucoma, diabetic, and pre/post-operation care. In addition, 20/20 maintains a wide selection of frame and lens inventory to ensure attractive product options for ages and styles.

Vision Source Names Michael Marcroft as VP of Marketing, Succeeding Randy Sones

By Staff
Monday, December 10, 2018 12:26 AM KINGWOOD, Texas—Vision Source, the largest network of private practice optometrists in North America, has named Michael Marcroft as its new vice president of marketing. He joins the network’s senior leadership team as of today (Monday, Dec.10) and will replace Randy Sones, who is currently vice president of marketing. Sones is retiring after a 27-year working history with Vision Source, according to an announcement. Marcroft will be responsible for the organization’s overall marketing strategies, initiatives and communications.

American Vision Announces ‘Strategic Partnership’ With McDougal Eye Center

By Staff
Monday, December 10, 2018 12:24 AM TEMPE, Ariz.—American Vision Partners, a private-equity backed practice management organization, and Southwestern Eye Center, an affiliate of American Vision Partners, said late last week they have established a “strategic partnership” with Mesa, Ariz.-based McDougal Eye Center. “The affiliation of the two businesses will improve the quality of care for patients in the Mesa area by bringing more comprehensive vision care services to the community,” American Vision said in its announcement. The terms of the transaction were not disclosed.

Rodenstock USA Expands Sales Territories for Its Brands, Including Porsche Design Eyewear

By Staff
Monday, December 10, 2018 12:21 AM SHERIDAN, Wyo.– Rodenstock USA has been expanding the availability of its Rodenstock and Rocco collections in the U.S. market. As of July 1, Rodenstock USA has been the exclusive distributor of Porsche Design Eyewear in the U.S. and Canada, as VMAIL reported. Since the addition of that collection, the company has been aggressively expanding its sales territories, according to Rodenstock USA president, Chris Juergens. Currently, the company is selectively working with accounts in Massachusetts as well as New Jersey/Pennsylvania/New York City, Virginia, West Virginia, Maryland, Georgia, North and South Florida, Greater Houston, Kansas City, St. Louis, Southern California and Portland to Seattle.

Carl Zeiss Meditec Posts Year-End Revenue Gains

By Staff
Monday, December 10, 2018 12:18 AM JENA, Germany—Carl Zeiss Meditec AG (ISIN: DE 0005313704) reported an increase in revenue for all strategic business units and regions after 12 months of fiscal year 2017/18. Revenue increased by 7.6 percent, or 11.1 percent when adjusted for currency effects, to €1,280.9 million, up from €1,189.9 million in the prior year. Earnings before interest and taxes (EBIT) rose to €197.1 million, versus €180.8 million year ago. The EBIT margin remained stable at 15.4 percent compared with prior year.

FTC Settlement Shuts Down Online Seller of Decorative Contact Lenses

By Staff
Monday, December 10, 2018 12:15 AM WASHINGTON—A California-based online seller of non-corrective, decorative contact lenses will pay a $60,000 penalty and be banned from all contact lens sales, according to an order issued last week by the Federal Trade Commission that settles FTC allegations that the online retailer has violated the Contact Lens Rule since at least 2014. (Overall, a U.S. District court imposed a $575,000 judgment, but much of it is being suspended.)

Prevent Blindness' Center for Vision and Population Health Targets National Eye Health Efforts

By Staff
Friday, December 7, 2018 12:30 AM CHICAGO—Prevent Blindness is launching the Center for Vision and Population Health (CVPH) at Prevent Blindness. The new Center will work in direct collaboration with experts from medical, scientific, public health, research and corporate sectors, leverage key stakeholder input, data from improved surveillance efforts (including state and national survey data), and peer-reviewed scientific literature to identify areas of geographic, population, and disease significance that provide opportunities for significant impact. The launch coincides with a paper issued by JAMA Ophthalmology yesterday, titled “Eye and Vision Health for Tomorrow: From Recommendations to Coordinated Action,” which provides strategies to coordinate national efforts to protect vision.

The Cooper Companies Report Record Revenues for Fiscal 2018

By Staff
Friday, December 7, 2018 12:27 AM PLEASANTON, Calif.—The Cooper Companies (NYSE: COO) on Thursday reported that sales in the fourth quarter rose 16 percent to $651.5 million, while fiscal 2018 sales increased 18 percent to $2.53 billion. The reporting periods ended Oct. 31, according to the announcement. “This was a year of record revenues, non-GAAP [earnings per share] and free cash flow,” Cooper president and chief executive officer Albert White said in the announcement. “I am proud of our team for everything we accomplished and believe our growth strategies are working and our momentum remains strong.”

FGX International Acquires Online Retailer, One Click Ventures

By Staff
Friday, December 7, 2018 12:24 AM GREENWOOD, Ind.—One Click Ventures, an online retailer that sells prescription and nonprescription glasses, has been acquired by FGX International. The deal closed during the third quarter, but One Click publicly announced the news on Dec. 4. Financial terms were not disclosed. One Click’s e-commerce brands include felix + iris, Readers.com, and Sunglass Warehouse. The company said it will continue to operate as a standalone business and will maintain its existing Greenwood operations and that CEO and co-founder Randy Stocklin will continue to lead the company.

GrandVision Reports Highest Quarterly Comparable Growth in Three Years

By Staff
Friday, December 7, 2018 12:21 AM SCHIPHOL, The Netherlands—GrandVision NV reported recently that its third-quarter revenue rose 13.3 percent at constant exchange rates and comparable growth rose 5.1 percent in the period. Revenue totaled €948 million in the recent quarter, compared with €858 million in the year-ago period. The increases were “driven by a particularly strong performance in the G4 and Americas & Asia segments,” the company said in its announcement. (The G4 segment includes operations in Belgium, Netherlands, Luxembourg, France, Monaco, Austria, Germany, Ireland and the U.K.)

FDA Issues Approval for Bausch + Lomb's Multifocal Contact Lens for Astigmatism

By Staff
Friday, December 7, 2018 12:18 AM BRIDGEWATER, N.J.—Bausch + Lomb, a global eye health company, said Wednesday that the Food and Drug Administration (FDA) has issued 510(k) clearance for Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses. This is the first multifocal toric lens to be available as a standard offering in the eyecare professional's fit set, according to the announcement. The lens is the “most advanced soft contact lens design in the history of Bausch + Lomb,” according to the announcement, and the monthly silicone hydrogel lens “builds upon the success of Bausch + Lomb Ultra for Presbyopia and Bausch + Lomb Ultra for Astigmatism lenses.” Bausch + Lomb is a wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TSX: BHC).

Notal Vision Receives FDA Breakthrough Device Designation for OCT System

By Staff
Friday, December 7, 2018 12:15 AM MANASSAS, Va.— The U.S. Food and Drug Administration (FDA) granted "breakthrough device” designation to Notal Vision’s home-based Optical Coherence Tomography (OCT) System, according to an announcement from Notal. The privately-held ophthalmic diagnostic services company focuses on extending ophthalmic disease management from the clinic to the home. The FDA’s device program was established in 2016 to helps patients with diagnosis of life-threatening diseases gain timely access to breakthrough technologies. This designation indicates that the FDA intends to provide interactive communication with the sponsor during device development and throughout the review process for various types of premarket submissions.

Takeda, Shire Shareholders Approve Steps Toward Completing Planned Deal

By Staff
Thursday, December 6, 2018 12:27 AM OSAKA, Japan—Takeda Pharmaceutical Co. (TSE: 4502) and Shire plc (LON: SHP) moved closer on Wednesday to completing Takeda’s $60 billion planned acquisition of Shire. Takeda, based here, announced that the offering terms for the issuance of new Takeda shares, which is required to implement the proposed acquisition, was approved as proposed by at least 88 percent of shareholders’ votes. The results were announced following an extraordinary general meeting of shareholders here. In a separate announcement, Shire said its shareholders also voted to approve the deal. Takeda and Shire had agreed, in May, on the terms of a recommended cash and share offer to be made by Takeda.

The Vision Council Names Business Executive George Blankenship as 2019 Executive Summit Keynote Speaker

By Staff
Thursday, December 6, 2018 12:24 AM ALEXANDRIA, Va.—The Vision Council’s 2019 Executive Summit lineup is rounding out with the announcement of George Blankenship, former executive at Apple Computer, Tesla Motors and GAP Inc., as the keynote speaker, according to an announcement from the Vision Council. With three decades of experience in international strategy, retail and real estate, Blankenship is best known for his growth strategies focused on customer experience, implemented in his work with such notable and impactful companies. As the greater vision and vision care industry continues to evolve and expand, Blankenship will offer a unique perspective on how organizations within the industry can adapt to an ever changing marketplace.

Ocuco Appoints Dr. Ian Lane as U.S. Product Director and Chief Medical Officer

By Staff
Thursday, December 6, 2018 12:21 AM DUBLIN, Ireland—Ocuco, a leading global eyecare software company, has appointed Dr. Ian Lane, OD, FAAO to the position of U.S. product director and chief medical officer, focusing on Ocuco’s flagship product, Acuitas. Dr. Lane brings 30 years of U.S. eyecare experience to Ocuco. After leaving the University of Houston, in Texas in 1982, Dr. Lane started in practice in California as an independent optometrist. He became involved in the early days of U.S. EHR and practice management systems while still in practice, which migrated into a full-time career.